ArticleMedical oncology (Northwood, London, England)2018

Uncommon frame-shift exon 19 EGFR mutations are sensitive to EGFR tyrosine kinase inhibitors in non-small cell lung carcinoma.

Giuseppina Improta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.